Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status

被引:0
|
作者
Jinghui Wang
Yujie Dong
Yiran Cai
Lijuan Zhou
Shafei Wu
Guimei Liu
Dan Su
Xi Li
Na Qin
Jingying Nong
Hongyan Jia
Quan Zhang
Jing Mu
Xuan Zeng
Haiqing Zhang
Shucai Zhang
Zongde Zhang
机构
[1] Capital Medical University,Department of Medical Oncology, Beijing Thoracic Tumor and Tuberculosis Research Institute, Beijing Chest Hospital
[2] Capital Medical University,Department of Pathology, Beijing Thoracic Tumor and Tuberculosis Research Institute, Beijing Chest Hospital
[3] Chinese Academy of Medical Sciences,Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College
[4] Capital Medical University,Department of Radiotherapy, Beijing Thoracic Tumor and Tuberculosis Research Institute, Beijing Chest Hospital
[5] Capital Medical University,Department of Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Beijing Thoracic Tumor and Tuberculosis Research Institute, Beijing Chest Hospital
关键词
EGFR; KRAS; ALK; Lung adenocarcinoma; Fluorescent in situ hybridization;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:453 / 460
页数:7
相关论文
共 50 条
  • [21] Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations
    J. Y. Zhou
    J. Zheng
    Z. F. Yu
    W. B. Xiao
    J. Zhao
    K. Sun
    B. Wang
    X. Chen
    L. N. Jiang
    W. Ding
    J. Y. Zhou
    European Radiology, 2015, 25 : 1257 - 1266
  • [22] Lung Adenocarcinoma in Young Adults: EGFR/KRAS/ALK Mutation Status and Clinicopathological Features in 64 Patients under Age 40
    Dogan, S.
    Jhanwar, S. C.
    Ladanyi, M.
    Zakowski, M. F.
    MODERN PATHOLOGY, 2011, 24 : 407A - 408A
  • [23] ALK REARRANGEMENTS IN TURKISH PATIENTS WITH LUNG ADENOCARCINOMA
    Atli, E. I.
    Yakicier, M. C.
    Akin, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E37 - E37
  • [24] ALK rearrangements in Turkey series lung adenocarcinoma
    Atli, E. I.
    Akin, A.
    Yakicier, C.
    FEBS JOURNAL, 2014, 281 : 433 - 433
  • [25] EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
    Colombino, Maria
    Paliogiannis, Panagiotis
    Cossu, Antonio
    Santeufemia, Davide Adriano
    Lung, Sardinian
    Sini, Maria Cristina
    Casula, Milena
    Palomba, Grazia
    Manca, Antonella
    Pisano, Marina
    Doneddu, Valentina
    Palmieri, Giuseppe
    Pazzola, Antonio
    Fadda, Giovanni Maria
    Pirina, Pietro
    Fois, Alessandro
    Putzu, Carlo
    Ginesu, Giorgio
    Porcu, Alberto
    Astara, Giorgio
    Scartozzi, Mario
    Carta, Anna Maria
    Defraia, Efisio
    Guerzoni, Daniela
    Porcu, Giuseppe
    Bardino, Gianfranco
    Sini, Claudio
    Capelli, Francesca
    Sarobba, Maria Giuseppina
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [26] EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
    Maria Colombino
    Panagiotis Paliogiannis
    Antonio Cossu
    Davide Adriano Santeufemia
    Maria Cristina Sini
    Milena Casula
    Grazia Palomba
    Antonella Manca
    Marina Pisano
    Valentina Doneddu
    Giuseppe Palmieri
    BMC Pulmonary Medicine, 19
  • [27] Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
    Zito Marino, Federica
    Liguori, Giuseppina
    Aquino, Gabriella
    La Mantia, Elvira
    Bosari, Silvano
    Ferrero, Stefano
    Rosso, Lorenzo
    Gaudioso, Gabriella
    De Rosa, Nicla
    Scrima, Marianna
    Martucci, Nicola
    La Rocca, Antonello
    Normanno, Nicola
    Morabito, Alessandro
    Rocco, Gaetano
    Botti, Gerardo
    Franco, Renato
    PLOS ONE, 2015, 10 (09):
  • [28] Immunohistochemistry versus DNA testing for detection of EGFR mutations and ALK rearrangements in lung adenocarcinoma patients
    Skronski, Michal
    Langfort, Renata
    Giedronowicz, Dorota
    Jagus, Paulina
    Szpechcinski, Adam
    Chorostowska-Wynimko, Joanna
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [29] Clinicopathologic characteristics and survival outcome in patients with advanced lung adenocarcinoma and KRAS mutation
    Yang, Shifeng
    Yu, Xinmin
    Fan, Yun
    Shi, Xun
    Jin, Ying
    JOURNAL OF CANCER, 2018, 9 (16): : 2930 - 2937
  • [30] Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status
    Planck, Maria
    Edlund, Karolina
    Botling, Johan
    Micke, Patrick
    Isaksson, Sofi
    Staaf, Johan
    PLOS ONE, 2013, 8 (10):